The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Half- vs Full-Dose Trivalent Inactivated Influenza Vaccine (2004-2005): Age, Dose, and Sex Effects on Immune Responses
Abstract
BACKGROUND: Optimal public health strategies for managing influenza vaccine shortages are not yet defined. Our objective was to determine the effects of age, sex, and dose on the immunogenicity of intramuscular trivalent inactivated vaccine (TIV). METHODS: Healthy adults aged 18 to 64 years, stratified by age (18-49 and 50-64 years) and sex, were randomized to receive full- or half-dose TIV. Hemagglutination inhibition titers against vaccine antigens were measured before and 21 days after immunization. A primary outcome of noninferiority was defined as a difference of less than 20% in the upper 95% confidence interval (CI) of the proportion of subjects with strain-specific hemagglutination inhibition antibody titers of 1:40 or higher after vaccination. Secondary outcomes included geometric mean titers, after vaccination side effects, and occurrences of influenza-like illnesses. RESULTS: Among previously immunized subjects (N = 1114) receiving half- vs full-dose TIV (age, 18-49 years, n = 284 [half] and n = 274 [full]; and age 50-64 years, n = 276 [half] and n = 280 [full]), CIs for proportions of subjects with hemagglutination inhibition antibody titers of 1:40 or higher excluded substantial reduction for all antigens in the 18- to 49-year age group and for B/Shanghai/361/2002 (B) and A/Fujian/411/2002 (A/H3N2) in the 50- to 64-year age group. Geometric mean titer in the female 18- to 49-year age group exceeded male responses for all strains: responses to half-dose TIV that were comparable with male full-dose responses for A/New Caledonia/20/99 (A/H1N1) antigen, 25.4 (95% CI, 20.9-30.9) vs 25.6 (95% CI, 21.3-30.9); A/H3N2 antigen, 60.8 (95% CI, 50.8-72.7) vs 44.1 (95% CI, 37.6-51.8); and B antigen, 64.4 (95% CI, 53.9-76.9) vs 60.7 (95% CI, 51.4-71.7) (findings were similar for the 50- to 64-year age group). Some injection site and systemic reactions (myalgias and/or arthralgias [P < .05], headache [P < .001], and impact of fatigue [P < .05]) were significantly lower in men. The relative risk of medical visits and hospitalizations for influenza-like illnesses were similar in the half- and full-dose groups regardless of age. CONCLUSIONS: Antibody responses to intramuscular half-dose TIV in healthy, previously immunized adults were not substantially inferior to the full-dose vaccine, particularly for ages 18 to 49 years. Significantly higher geometric mean titer responses in women were identified for all ages, regardless of dose or influenza strain. Half-dose vaccination may be an effective strategy for healthy adults younger than 50 years in the setting of an influenza vaccine shortage.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Food, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
(2001) · PsycEXTRA Dataset · doi:10.1037/e548312006-001 · Cited by 5,011
Mortality Associated With Influenza and Respiratory Syncytial Virus in the United States
Thompson, W. W., Shay, D. K., Weintraub, E., Brammer, L., Cox, N., Anderson, L. J., & Fukuda, K. (2003) · JAMA · doi:10.1001/jama.289.2.179 · Cited by 3,673
Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease
Omenn, G. S., Goodman, G. E., Thornquist, M. D., Balmes, J., Cullen, M. R., Glass, A., Keogh, J. P., Meyskens, F. L., Valanis, B., Williams, J. H., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199605023341802 · Cited by 3,638
Lichtenstein, A. H., Appel, L. J., Brands, M., Carnethon, M., Daniels, S., Franch, H. A., Franklin, B., Kris-Etherton, P., Harris, W. S., Howard, B., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.176158 · Cited by 2,705
Kushi, L. H., Byers, T., Doyle, C., Bandera, E. V., McCullough, M., Gansler, T., Andrews, K. S., Thun, M. J., & The American Cancer Society 2006 Nutrition and Physical Activity Guidelines Advisory Committee (2006) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.5.254 · Cited by 1,901
(2002) · PsycEXTRA Dataset · doi:10.1037/e548512006-001 · Cited by 1,708
Sex differences in autoimmune disease
Whitacre, C. C. (2001) · Nature Immunology · doi:10.1038/ni0901-777 · Cited by 1,271
Lee, I.-M., Cook, N. R., Gaziano, J. M., Gordon, D., Ridker, P. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.1.56 · Cited by 1,137
Sex hormones and the immune response in humans
Bouman, A., Heineman, M. J., & Faas, M. M. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi008 · Cited by 1,131
Nichol, K. L., Margolis, K. L., Wuorenma, J., & Von Sternberg, T. (1994) · New England Journal of Medicine · doi:10.1056/nejm199409223311206 · Cited by 996
Folic Acid for the Prevention of Colorectal Adenomas: A Randomized Clinical Trial
Cole, B. F., Baron, J. A., Sandler, R. S., Haile, R. W., Ahnen, D. J., Bresalier, R. S., McKeown-Eyssen, G., Summers, R. W., Rothstein, R. I., Burke, C. A., et al. (2007) · JAMA · doi:10.1001/jama.297.21.2351 · Cited by 929
Vaccines for preventing influenza in healthy adults
Jefferson, T., Di Pietrantonj, C., Rivetti, A., Bawazeer, G. A., Al-Ansary, L. A., & Ferroni, E. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001269.pub4 · Cited by 896
Calcium Supplements for the Prevention of Colorectal Adenomas
Baron, J. A., Beach, M., Mandel, J. S., van Stolk, R. U., Haile, R. W., Sandler, R. S., Rothstein, R., Summers, R. W., Snover, D. C., Beck, G. J., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400204 · Cited by 865
A Clinical Trial of Antioxidant Vitamins to Prevent Colorectal Adenoma
Greenberg, E. R., Baron, J. A., Tosteson, T. D., Freeman, D. H., Beck, G. J., Bond, J. H., Colacchio, T. A., Coller, J. A., Frankl, H. D., Haile, R. W., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407213310301 · Cited by 762
Carman, Elder, Wallace, & Mcaulay (2000) · The Lancet · Cited by 675
The Effectiveness of Vaccination against Influenza in Healthy, Working Adults
Nichol, K. L., Lind, A., Margolis, K. L., Murdoch, M., McFadden, R., Hauge, M., Magnan, S., & Drake, M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510053331401 · Cited by 673
Potter, J., Stott, D. J., Roberts, M. A., Elder, A. G., O'Donnell, B., Knight, P. V., & Carman, W. F. (1997) · Journal of Infectious Diseases · doi:10.1093/infdis/175.1.1 · Cited by 660
Langer, R. D., White, E., Lewis, C. E., Kotchen, J. M., Hendrix, S. L., & Trevisan, M. (2003) · Annals of Epidemiology · doi:10.1016/s1047-2797(03)00047-4 · Cited by 630
(2004) · PsycEXTRA Dataset · doi:10.1037/e548622006-001 · Cited by 471
Genetic control of the CD4/CD8 T-cell ratio in humans
Amadori, A., Zamarchi, R., De Silvestro, G., Forza, G., Cavatton, G., Danieli, G. A., Clementi, M., & Chieco-Bianchi, L. (1995) · Nature Medicine · doi:10.1038/nm1295-1279 · Cited by 440
Clements, M. L., Betts, R. F., Tierney, E. L., & Murphy, B. R. (1986) · Journal of Clinical Microbiology · doi:10.1128/jcm.24.1.157-160.1986 · Cited by 435
Dose Sparing with Intradermal Injection of Influenza Vaccine
Kenney, R. T., Frech, S. A., Muenz, L. R., Villar, C. P., & Glenn, G. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa043540 · Cited by 422
Antioxidant Vitamin Supplements and Cardiovascular Disease
Kris-Etherton, P. M., Lichtenstein, A. H., Howard, B. V., Steinberg, D., & Witztum, J. L. (2004) · Circulation · doi:10.1161/01.cir.0000137822.39831.f1 · Cited by 408
Dietary Carotenoids and Vitamins A, C, and E and Risk of Breast Cancer
Zhang, S., Hunter, D. J., Forman, M. R., Rosner, B. A., Speizer, F. E., Colditz, G. A., Manson, J. E., Hankinson, S. E., & Willett, W. C. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.6.547 · Cited by 397
Keech, M., Scott, A. J., & Ryan, P. J. J. (1998) · Occupational Medicine · doi:10.1093/occmed/48.2.85 · Cited by 383
Christen, W. G., Gaziano, J. M., & Hennekens, C. H. (2000) · Annals of Epidemiology · doi:10.1016/s1047-2797(99)00042-3 · Cited by 376
Hercberg, S., Preziosi, P., Briançon, S., Galan, P., Triol, I., Malvy, D., Roussel, A.-M., & Favier, A. (1998) · Controlled Clinical Trials · doi:10.1016/s0197-2456(98)00015-4 · Cited by 358
Serum Antibody Responses after Intradermal Vaccination against Influenza
Belshe, R. B., Newman, F. K., Cannon, J., Duane, C., Treanor, J., Van Hoecke, C., Howe, B. J., & Dubin, G. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa043555 · Cited by 332
Rubertone, M. V., & Brundage, J. F. (2002) · American Journal of Public Health · doi:10.2105/ajph.92.12.1900 · Cited by 304
Americans' Views on the Use and Regulation of Dietary Supplements
Blendon, R. J., DesRoches, C. M., Benson, J. M., Brodie, M., & Altman, D. E. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.6.805 · Cited by 297
The efficacy, effectiveness and cost-effectiveness of inactivated influenza virus vaccines
Nichol, K. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00070-7 · Cited by 265
Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza
Nichol, K. L. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.5.749 · Cited by 258
Yetley, E. A. (2007) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/85.1.269s · Cited by 195
Safety of High Doses of Influenza Vaccine and Effect on Antibody Responses in Elderly Persons
Keitel, W. A., Atmar, R. L., Cate, T. R., Petersen, N. J., Greenberg, S. B., Ruben, F., & Couch, R. B. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.10.1121 · Cited by 187
Jackson, L. A., Austin, G., Chen, R. T., Stout, R. R., Destefano, F. R., Gorse, G. J., Newman, F. K., Yu, O., & Weniger, B. G. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00225-0 · Cited by 132
Vaccines for preventing influenza in healthy adults
Demicheli, V., Rivetti, D., Deeks, J. J., et al. (2001) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001269 · Cited by 126
Cancer-related behavior of vitamin supplement users.
Patterson, R. E., Neuhouser, M. L., White, E., Hunt, J. R., & Kristal, A. R. (1998) · PubMed · Cited by 88
Ruben, F. L., & Jackson, G. G. (1972) · The Journal of Infectious Diseases · doi:10.1093/infdis/125.6.656 · Cited by 73
Effect of influenza B virus infection on human performance.
Smith, A. P., Thomas, M., BROCKMAN, P., Kent, J., & Nicholson, K. G. (1993) · BMJ · doi:10.1136/bmj.306.6880.760 · Cited by 67
Strain variation in interferon γ production of BCG-sensitized mice challenged with PPD
Huygen, K., & Palfliet, K. (1984) · Cellular Immunology · doi:10.1016/0008-8749(84)90279-x · Cited by 58
Gulati, U., Kumari, K., Wu, W., Keitel, W. A., & Air, G. M. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.08.053 · Cited by 53
Transcutaneous immunization and immunostimulant strategies
Glenn, G. M., Kenney, R. T., Hammond, S. A., & Ellingsworth, L. R. (2003) · Immunology and Allergy Clinics of North America · doi:10.1016/s0889-8561(03)00094-8 · Cited by 50
Updated interim influenza vaccination recommendations--2004-05 influenza season.
(2004) · PubMed · Cited by 46
Loehrer, P. J. (2006) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)70418-8 · Cited by 38
Remarque, E. J., Jong, J. M. A. D., van der Klis, R. J., Masurel, N., & Ligthart, G. J. (1999) · Experimental Gerontology · doi:10.1016/s0531-5565(98)00060-6 · Cited by 20
Morris, C. D., & Carson, S. (2003) · ACC Current Journal Review · doi:10.1016/j.accreview.2003.08.034 · Cited by 4
Cited by
Sex differences in immune responses
Klein, S. L., & Flanagan, K. L. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.90 · Cited by 6,370
Sex and gender: modifiers of health, disease, and medicine
Mauvais-Jarvis, F., Bairey Merz, N., Barnes, P. J., Brinton, R. D., Carrero, J.-J., DeMeo, D. L., De Vries, G. J., Epperson, C. N., Govindan, R., Klein, S. L., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31561-0 · Cited by 2,001
Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission
Peckham, H., de Gruijter, N. M., Raine, C., Radziszewska, A., Ciurtin, C., Wedderburn, L. R., Rosser, E. C., Webb, K., & Deakin, C. T. (2020) · Nature Communications · doi:10.1038/s41467-020-19741-6 · Cited by 1,503
Impact of sex and gender on COVID-19 outcomes in Europe
Gebhard, C., Regitz-Zagrosek, V., Neuhauser, H. K., Morgan, R., & Klein, S. L. (2020) · Biology of Sex Differences · doi:10.1186/s13293-020-00304-9 · Cited by 1,306
Factors That Influence the Immune Response to Vaccination
Zimmermann, P., & Curtis, N. (2019) · Clinical Microbiology Reviews · doi:10.1128/cmr.00084-18 · Cited by 939
Metadata
- Authors
- Engler, R. J. M.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2008-12-08
- Volume
- 168
- Issue
- 22
- Pages
- 2405
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2171973389
- Cited by
- 320
- References
- 47
- FWCI
- 6.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.